Aurobindo Pharma Ltd
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
60.05 INR
34.86 B INR
314.03 B INR
278.94 M
About Aurobindo Pharma Ltd
Sector
Industry
CEO
Kambam Nithyananda Reddy
Website
Headquarters
Hyderabad
Founded
1986
IPO date
Jan 19, 1995
Identifiers
2
ISIN INE406A01037
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Related stocks
AUROPHARMA : Breakout RetestAurobindo Pharma has already given breakout now it is retesting the breakout levels. one can try on this levels with the strict stop-loss.
All data is available in public domain..
CMP : 1290
TG : 1400
SL : 1240
Stock's selection based on 5 Point Analysis:
1: Idea : Breakout Retest.
2: Sup
Breakout or Bull Trap? Auro Pharma at Major Supply Zone!Price is looking strong, momentum is building, and to most traders… this feels like a clean breakout. But if you shift your lens to a supply and demand perspective, the story changes completely. What looks like strength might actually be distribution.
📊 Multi-Timeframe Story – The Real Edge
When
AUROPHARMA – Aurobindo Pharma Ltd
📈 AUROPHARMA – Aurobindo Pharma Ltd | Monthly Trend Reversal & Breakout
Chart Type: 1M (Monthly)
CMP: ₹1,366.90
Breakout Confirmation: Above ₹1,330 (Clearing the recent swing high consolidation)
Support Zone: ₹1,150 – ₹1,200
Trend Structure: Forming a "V-shaped" recovery leading into a potenti
AUROPHARMA - weeklyThe overall trend in the stock has shifted from a prolonged consolidation phase to a fresh bullish structure. Price is now forming higher highs and higher lows while sustaining above key moving averages, indicating strength and a possible continuation of the uptrend.
The volume behavior supports th
Breakout of the chart for Aurobindo Pharma:What the chart is showing
Price is in a strong uptrend (higher highs + higher lows).
A rising trendline is acting as solid support — buyers are stepping in consistently.
Stock has tested resistance multiple times (~₹1,240 zone) earlier (marked with red arrows).
It has closed above that resistance z
AUROPHARMA : Adam & Eve reversal → continuation trade🔍 Indicator Checklist
1⃣ Trend: Uptrend (Higher High – Higher Low formation after base)
2⃣ 20 EMA (Orange): Price trading above → short-term bullish support
3⃣ 50 EMA (Blue dotted): Recently reclaimed → trend confirmation
4⃣ Volume: Breakout supported by decent volume expansion
5⃣ Structure: Strong
Aurobindo Pharma – Ascending Triangle BreakoutThe stock has been in deep consolidation for over a year, forming an ascending triangle structure on the daily timeframe.
Key observations:
• Multiple tests of the resistance zone
• Gradually rising demand trendline
• Long consolidation indicating supply absorption
Price has now broken above the
AUROPHARMA.. On the verge of breakout?????AUROPHARMA was trading in well defined channel & now has approached on the top of the same..
now stock is consolidating at the top and looking for a breakout..
But..
There is a resistance at around 1270 level from where it can face resistance and reenter the channel or we can say will retest the
AUROPHARMA — Compression Before ExpansionCMP: 1,208
The stock has spent months rotating between 1,150–1,250.
Supply has been absorbed multiple times without breakdown.
Higher lows are forming quietly above the 1,160–1,170 support cluster.
Short-term averages are turning up.
Momentum is rebuilding.
This is not a breakout yet — it’s positi
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of AUROPHARMA is 1,502.20 INR — it has increased by 0.78% in the past 24 hours. Watch Aurobindo Pharma Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Aurobindo Pharma Ltd stocks are traded under the ticker AUROPHARMA.
AUROPHARMA stock has risen by 4.81% compared to the previous week, the month change is a 11.93% rise, over the last year Aurobindo Pharma Ltd has showed a 22.13% increase.
We've gathered analysts' opinions on Aurobindo Pharma Ltd future price: according to them, AUROPHARMA price has a max estimate of 1,662.00 INR and a min estimate of 1,020.00 INR. Watch AUROPHARMA chart and read a more detailed Aurobindo Pharma Ltd stock forecast: see what analysts think of Aurobindo Pharma Ltd and suggest that you do with its stocks.
AUROPHARMA reached its all-time high on Sep 13, 2024 with the price of 1,592.00 INR, and its all-time low was 4.60 INR and was reached on Jan 4, 1999. View more price dynamics on AUROPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AUROPHARMA stock is 1.89% volatile and has beta coefficient of 0.30. Track Aurobindo Pharma Ltd stock price on the chart and check out the list of the most volatile stocks — is Aurobindo Pharma Ltd there?
Today Aurobindo Pharma Ltd has the market capitalization of 864.61 B, it has decreased by −2.74% over the last week.
Yes, you can track Aurobindo Pharma Ltd financials in yearly and quarterly reports right on TradingView.
Aurobindo Pharma Ltd is going to release the next earnings report on May 21, 2026. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA earnings for the last quarter are 15.67 INR per share, whereas the estimation was 15.94 INR resulting in a −1.71% surprise. The estimated earnings for the next quarter are 16.33 INR per share. See more details about Aurobindo Pharma Ltd earnings.
Aurobindo Pharma Ltd revenue for the last quarter amounts to 86.46 B INR, despite the estimated figure of 84.66 B INR. In the next quarter, revenue is expected to reach 87.37 B INR.
AUROPHARMA net income for the last quarter is 9.10 B INR, while the quarter before that showed 8.48 B INR of net income which accounts for 0.00% change. Track more Aurobindo Pharma Ltd financial stats to get the full picture.
Yes, AUROPHARMA dividends are paid quarterly. The last dividend per share was 4.00 INR. As of today, Dividend Yield (TTM)% is 0.27%. Tracking Aurobindo Pharma Ltd dividends might help you take more informed decisions.
Aurobindo Pharma Ltd dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.41% and 8.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 14, 2026, the company has 40.75 K employees. See our rating of the largest employees — is Aurobindo Pharma Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aurobindo Pharma Ltd EBITDA is 68.47 B INR, and current EBITDA margin is 20.54%. See more stats in Aurobindo Pharma Ltd financial statements.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aurobindo Pharma Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aurobindo Pharma Ltd technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aurobindo Pharma Ltd stock shows the strong buy signal. See more of Aurobindo Pharma Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









